A few days ago, Rock Health released the 2015 Digital Medical Consumer Orientation report. The report surveyed more than 4,000 Americans, spanning the entire summer, and hopes to answer the following questions that everyone is very concerned about: (1) What is the current market share of the major B2C digital health industry? (2) What is the main driver of consumer will? (3) What is the attitude of individuals towards data privacy? Who can users share trust data with?
The findings are surprising. We believe that users of digital health products are young, wealthy, educated and healthy people, but the results are unexpected. The survey found that personal attitudes toward health care (responsibility, self-management, and willingness to pay cash) are the main indicators of consumer willingness, and those who are unhealthy are more likely to consume than healthy ones. At the same time, we see that the market share of digital health products is still relatively low compared to other products.
The demand for consumer interaction in health care has never been higher, and nearly half of Americans have not even used a product in the main digital health field. There is no representative company in this consumer sector, and perhaps this is the biggest opportunity in the digital health arena.
Willingness
The main objective of the survey is to test the current market share of the six core digital health sectors in the B2C market environment.
(Source: Rock Health consumer survey data (n=4017), the following chart data source)
A number of digital health companies are committed to redefining the interaction between consumers and healthcare systems. These companies are trying to establish a direct consumer business model that produces the following six broad categories: Online Health Information (WebMD), Online Health Review (ZocDoc), Mobile Health Tracking (MyFitnessPal), Wearables (Fitbit), Consumer Driven gene services (23andMe), telemedicine systems (Doctor on Demand).
In the traditional medical field, consumers do not have independent decision-making power, and most of the payment behavior is done by the insurance company, but in essence the medical health service has always faced the individual. There is now an expectation in the industry: I want users to be responsible for their own money, forcing them to change their understanding of health and their willingness to manage.
The above picture shows the main components of the consumer health ecosystem in the healthcare industry, from understanding their health status to finding a doctor, tracking health and disease prevention, and finally receiving convenient medical services. It can be seen from the figure that the online search of medical information and the online evaluation of medical services have the highest awareness and willingness among consumers.
Digital healthcare still has a rapidly rising consumer curve, with nearly half of consumers using only one digital health product or none.
In the digital health classification of this survey, 80% of Americans used at least one of them. 48% of respondents have never used (non-adopters) or used only one of all listed technologies. Within the scope of the survey, only 2% of users have used 5 to 6 digital medical products , and these people are also known as super-adopters.
The key difference between Non-adopters and Super-adopters is that Super-adopters are younger, more trustworthy, and more likely to have a smartphone.
Searching for health information online is the most acceptable way, with 40% of respondents searching for information online and acting on the information they find.
The survey revealed historical search results for several specific health categories including diagnosis (symptom-based), treatment plan (diagnosis-based), prescription drug information, and supplemental information. Overall, 71% of respondents have searched for the information listed above, 6/10 of respondents search for prescription drug information (this is the highest ranked category), and the lowest ranked category is treatment, only Up to 50% of respondents will search online.
Hepatitis B Surface Antigen/AntibodyTest
INTENDED USE
Used for the qualitative detection of Hepatitis B surface
antigen in serum/plasma.
PRINCIPLE
The sample mixing up colloidal-gold monoclonal antibody move along the membrane to the T line, and form the T line when the human serum/plasma and whole blood contains HBsAg according to the principle of double antibody sandwich method and gold immunochromatography assay, which is a positive result. Unreacted markers move forward continuallyto combine with anti-mouse antibody and form a control line.
If the test line does not appear, it is a negative result.
MAIN COMPONENTS
Sample pad, colloidal gold marked pad, nitrocellulose membrane, absorbent paper and PVC board.
INTERPRETATION OF RESULTS
POSITIVE: Two distinct red lines appear. A red line in the
control region (C), and another red line in the test region (T). A pink to red line (T), even if it is very thin, indicates a positive
result.
NEGATIVE: A red line appears in the control region(C). No line
appears in the test region (T).
INVALID: No red lines appear or control line fails to appear.
Insufficient specimen volume or incorrect procedural
techniques are the most likely reasons. Review the procedure and repeat the test with a new test
device.
If the problem persists, discontinue using the kit and contact
your local distributor.
Hepatitis B Surface Antigen Test,Hepatitis B Test Kit,Medical Diagnostic Test Hepatitis B,Diagnostic Test Hbsag
Changchun ZYF science and technology CO.,LTD , https://www.zyf-medical.com